Table 3 Subgroup analysis of long-term survivors in complete remission with (CTx, n = 4) and without completion of full recommended chemotherapy regimen (no CTx, n = 4)
CTx | noCTx | |
|---|---|---|
Median (range) | Median (range) | |
Age (years) | 69 (65–70) | 57 (30–84) |
BMI (kg/m2) | 23.4 (23–32) | 24.5 (23–25) |
n (%) | ||
Gender (female/male) | 4/0 (100/0%) | 3/1 (75/25%) |
Smokers | 0 (0%) | 1 (25%) |
Alcohol abuse | 0 (0%) | 0 (0%) |
ASA Score [12] | ||
I | 1 (25%) | 0 (0%) |
II | 2 (50%) | 2 (50%) |
III | 1 (25%) | 2 (50%) |
IV | 0 (0%) | 0 (0%) |
Common comorbidities | ||
Hypertension | 1 (25%) | 3 (75%) |
Post pancreatitis | 2 (50%) | 2 (50%) |
Hepatic disease | 1 (25%) | 0 (0%) |
Coronary heart disease | 0 (0%) | 0 (0%) |
Pulmonary disease | 0 (0%) | 0 (0%) |
Renal insufficiency | 0 (0%) | 1 (25%) |
Diabetes | 1 (25%) | 0 (0%) |
Localization of tumor | ||
Head | 3 (75%) | 4 (100%) |
Body | 1 (25%) | 0 (0%) |
Tail | 0 (0%) | 0 (0%) |
Grading of tumor | ||
G2 | 3 (75%) | 4 (100%) |
G3 | 0 (0%) | 0 (0%) |
G4 | 1 (25%) | 0 (0%) |
Invasion of lymph nodes (N) | ||
N0 | 2 (50%) | 2 (50%) |
N1 | 2 (50%) | 2 (50%) |
Type of surgery | ||
Pancreatoduodenectomy | 3 (75%) | 4 (100%) |
Distal pancreatectomy | 1 (25%) | 0 (0%) |
Total pancreatectomy | 0 (0%) | 0 (0%) |
Complications | ||
Intraoperative complication | 0 (0%) | 0 (0%) |
Postoperative complication | 3 (75%) | 2 (50%) |
Operative revision | 0 (0%) | 0 (0%) |
Median (range) | Median (range) | |
Hospital stay (days) | ||
Overall | 17 (14–45) | 21 (16–31) |
Intensive care unit | 5 (3–6) | 7 (4–7) |
Drain remove (days) | 6 (3–45) | 7 (5–8) |